HTGC

NYSE: HTGC (Stock Quote) $13.39 $-0.10 -0.74%
NYSE: HTGZ (Bond Quote) $25.98 $-0.06 -0.23%
NYSE: HTGY (Bond Quote) $25.63 $-0.21 -0.81%
  • Company
    • Investment Focus
    • Financing Solutions
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Venture Capital & Private Equity
    • Giving Back to the Community
    • Careers
  • Team
    • Investment Professionals
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Management
    • Board of Directors
    • Team A-Z
  • Portfolio
    • Technology
    • Cleantech
    • Life Science
    • Special-Opportunity Lower Middle Market
    • Exit History
    • A-Z Portfolio List
  • Investor Relations
    • News & Events
      • Press Releases
      • Webcasts & Events
    • Financials & Filings
      • Analyst Coverage
      • Annual Reports
      • Dividends
        • Dividend Reinvestment Plan
      • Financial Statements
      • Quarterly Results
      • SEC Filings
      • Stock Information
        • Stock Performance
        • Historic Stock Lookup
        • Calculator
      • Tax Information
      • Email Alert Subscription
    • Corporate Governance
      • Corporate Governance Guidelines
      • Audit Committee
      • Compensation Comittee
      • Insider Ownership
      • Insider Transactions
    • Company Information
      • Company Information
      • Executive Management
      • Investor FAQs
      • IR Contact
      • Major Shareholders
    • Credit Ratings
    • What is a BDC
    • Shareholder Tools
      • Investor Briefcase
      • Download Library
      • Printed Materials
      • RSS News Feeds
  • News & Events
    • Press Releases
    • Hercules in the News
    • Portfolio Company News
    • Webcast & Events
  • Venture Debt
  • Contact

Life Science

We work with life sciences companies at all stages of development from developing novel drug therapies to production of new cost-saving medical devices.

Life Science companies can leverage Hercules debt financing solutions to speed time to market, broaden the scope of their clinical development and research, invest in new capabilities to reach important growth milestones, or shore-up the balance sheet ahead of an IPO or negotiations with strategic partners.
  • Biotechnology (including Diagnostics)
  • Drug Discovery & Drug Delivery
  • Healthcare Services
  • Life Sciences Instrumentation
  • Medical Devices
  • Specialty Pharmaceuticals
  • Among Others
  • Technology
  • CleanTech
  • Life Science
  • Special-Opportunity Lower Middle Market
  • Exit History
  • A-Z Portfolio List

Resources

  • Case Studies
  •  
     
    Aveo Pharmaceuticals, Inc.
      Venture Debt Accelerates New R&D and Supports Rapid Scale-up
  •  
     
    Cempra, Inc.
      Venture Debt Strengthens Balance Sheet Ahead of IPO
  •  
     
    Nupathe, Inc.
      Venture Debt Financing Sets Stage for Product Launch
  •  
     
    Pacira Pharmaceuticals, Inc.
      Venture Debt Helps to Strengthen Balance Sheet Ahead of IPO
     
     
    Sonacare Medical
      Venture Debt Accelerates FDA Clinical Submission
Home » Portfolio » Life Science
Acceleron
Pharma, Inc
AcelRx
Pharmaceuticals
Adiana
ADMA
Biologics, Inc
Aegerion
Pharmaceuticals
Alexza
Pharmaceuticals
Anacor
Pharmaceuticals, Inc.
Anthera
Pharmaceuticals
Aveo
Pharmaceuticals
BARRx
BIND Therapeutics
Cell
Therapeutics, Inc.
Cempra, Inc
Chroma
Therapeutics
Concert
Pharmaceuticals
Coronado
Biosciences
Crux Biomedical
deCODE Genetics
Dicerna
Pharmaceuticals
EKOS
ENTrigue Surgical
EpiCept
Guava
Technologies
Gynesonics
Horizon
Therapeutics
Insmed
Pharmaceuticals
Intelliject
Kamada
Labcyte
LaboPharm
Light Sciences
Oncology
Medrobotics
MELA Sciences, Inc.
Memory
Pharmaceuticals
Merrimack
Pharmaceuticals
Merrion
Pharmaceuticals
Navidea
Biopharmaceuticals, Inc.
Neosil
Neuralstem, Inc.
NeurogesX, Inc.
NextWave
Pharmaceuticals
NinePoint
Medical
Novasys Medical
NuGEN
Technologies
NuPathe Inc.
Omrix
Biopharmaceuticals
Omthera
Pharmaceuticals, Inc.
Optiscan
Biomedical
Oraya Therapeutics
Pacira
Pharmaceuticals
Paratek
Pharmaceuticals
Portola
Pharmaceuticals
Power Medical
Interventions
QuatRx
Pharmaceuticals
Recoly
Revance
Therapeutics, Inc.
Sirtris
Pharmaceuticals
SonaCare Medical
Tethys Bioscience
Transcept
Pharmaceuticals
TransMedics
United Orthopedic
Group, Inc.

© 2013 Hercules Technology Growth Capital. All rights reserved. Problems with the site? Email webmaster@htgc.com
Terms of Use & Privacy Policy
*Historical, intraday and current end-of-day data provided by eSignal. Intraday data is at least 20-minutes delayed.